Analysts Set The Cooper Companies, Inc. (NASDAQ:COO) PT at $117.00

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $117.00.

A number of research firms have recently weighed in on COO. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Stifel Nicolaus restated a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Finally, Robert W. Baird lifted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th.

Cooper Companies Stock Performance

NASDAQ COO opened at $100.80 on Wednesday. The stock has a market cap of $20.07 billion, a P/E ratio of 56.00, a PEG ratio of 2.15 and a beta of 0.99. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. Cooper Companies has a twelve month low of $82.21 and a twelve month high of $112.38. The company’s 50-day simple moving average is $105.91 and its 200 day simple moving average is $98.34.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same period in the prior year, the company posted $0.84 earnings per share. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, research analysts forecast that Cooper Companies will post 3.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This trade represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. boosted its stake in Cooper Companies by 43.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after buying an additional 10,616 shares in the last quarter. Axxcess Wealth Management LLC grew its holdings in Cooper Companies by 298.4% during the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after acquiring an additional 6,150 shares during the last quarter. Public Employees Retirement Association of Colorado increased its position in Cooper Companies by 298.9% in the 1st quarter. Public Employees Retirement Association of Colorado now owns 245,793 shares of the medical device company’s stock valued at $24,938,000 after acquiring an additional 184,171 shares during the period. Diversify Advisory Services LLC acquired a new position in shares of Cooper Companies during the second quarter worth $501,000. Finally, BDF Gestion bought a new stake in shares of Cooper Companies in the second quarter worth $2,919,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.